WINDLAS BIOTECH
Back to Income Statement
|
WINDLAS BIOTECH Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹760 Cr | ₹631 Cr | ₹513 Cr | ₹466 Cr | ₹428 Cr |
What is the latest Revenue of WINDLAS BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹760 Cr |
| Mar2024 | ₹631 Cr |
| Mar2023 | ₹513 Cr |
| Mar2022 | ₹466 Cr |
| Mar2021 | ₹428 Cr |
How is Revenue of WINDLAS BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹760 Cr | 20.43 | |
| Mar2024 | ₹631 Cr | 22.97 | |
| Mar2023 | ₹513 Cr | 10.12 | |
| Mar2022 | ₹466 Cr | 8.96 | |
| Mar2021 | ₹428 Cr | - | |
Compare Revenue of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,595.7 Cr | -2.8% | -7.6% | -5.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -2.8% |
-7.6% |
-5.1% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses